Ridgewood Investments’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
BPC
AWA
ACM
BPCE
EDRH
Ridgewood Investments's SOPH Position: Q3 2025 in Review
Ridgewood Investments sold out of SOPHiA GENETICS (SOPH) in Q3 2025, closing a stake of 34,449 shares — an estimated $107K sold.
Ridgewood Investments first reported a position in SOPH in Q4 2024 and held it in 3 quarters. The position peaked at $135K in Q1 2025. 40 funds tracked by Wall St. Rank hold SOPH as of Q3 2025.
- Ridgewood Investments reported no remaining SOPHiA GENETICS position as of Q3 2025 after selling out during the quarter.
- Ridgewood Investments sold 34,449 SOPHiA GENETICS shares in Q3 2025, an estimated $107K.
- Ridgewood Investments first reported a position in SOPHiA GENETICS in Q4 2024 and held it in 3 quarters.
- Ridgewood Investments's SOPHiA GENETICS position peaked at $135K in Q1 2025.
- 40 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2025.
Based on Ridgewood Investments's 13F filing for Q3 2025, filed 30 Oct 2025.